Is there enough evidence to support use of N-acetylcysteine in contrast-induced nephropathy?
Gonzales
Denise A
DA
Star
Robert A
RA
Kern
Steven J
SJ
Natanson
Charles
C
Danner
Robert L
RL
D000111:Acetylcysteine / Q000627:therapeutic use*; D003287:Contrast Media / Q000009:adverse effects*; D006801:Humans; D007674:Kidney Diseases / Q000139:chemically induced* / Q000517:prevention & control*
D003287:Contrast Media; D000111:Acetylcysteine